Researchers demonstrate RAS dimers are essential for cancer

by Cathy Frisinger,UT Southwestern Medical CenterRAS oncogenes work in pairs, known as "dimers." Credit: UT SouthwesternMutated RAS genes are some of the most common genetic drivers of

Updated on: June 01,2024

Researchers demonstrate RAS dimers are essential for cancer

by Cathy Frisinger,UT Southwestern Medical CenterRAS oncogenes work in pairs, known as "dimers." Credit: UT SouthwesternMutated RAS genes are some of the most common genetic drivers of

Updated on:June 01,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on: June 24,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on:June 24,2024

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on: March 12,2024

Study identifies a genetic driver of deadly prostate cancer

by Cedars-Sinai Medical CenterGraph shows elevated activity of a transcription-factor network that includes the molecule Onecut2 in tumors of patients whose prostate cancer resisted hormone thera

Updated on:March 12,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on: June 06,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on:June 06,2024

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are

Updated on: May 13,2024

Pancreatic cancer: Less toxic, more enduring drug may improve therapy

by Columbia University Irving Medical CenterIn preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are

Updated on:May 13,2024

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on: January 15,2024

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on:January 15,2024

A cell culture system with temperature gradients to study optimal conditions for effective hyperthermia

by Beijing Institute of Technology Press Co.The temperature gradation on a metallic culture surface facilitates immediate and accurate control of cellular temperature stimuli, as well as simultaneous

Updated on: February 01,2024

A cell culture system with temperature gradients to study optimal conditions for effective hyperthermia

by Beijing Institute of Technology Press Co.The temperature gradation on a metallic culture surface facilitates immediate and accurate control of cellular temperature stimuli, as well as simultaneous

Updated on:February 01,2024

Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

by Barcelona Institute for Global HealthCredit: Pixabay/CC0 Public DomainThe nitrate ingested over the course of a person's adult lifetime through the consumption of tap water and bottled wat

Updated on: February 18,2024

Long-term exposure to nitrates in drinking water may be a risk factor for prostate cancer

by Barcelona Institute for Global HealthCredit: Pixabay/CC0 Public DomainThe nitrate ingested over the course of a person's adult lifetime through the consumption of tap water and bottled wat

Updated on:February 18,2024

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on: June 19,2024

Researchers find new treatment for prostate cancer

by University of Oslo“We think that what we found is really exciting", says Professor Fahri Saatcioglu. Credit: University of OsloProfessor Fahri Saatcioglu at University of Oslo's Depar

Updated on:June 19,2024

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on: April 01,2024

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on:April 01,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on: March 30,2024

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on:March 30,2024

New study shows polymersomes' potential in cancer immunotherapy

byEindhoven University of TechnologySchematic overview of the study. Credit:Nature Nanotechnology(2024). DOI: 10.1038/s41565-024-01727-wWithin an international collaboration of 30 sc

Updated on: August 28,2024

New study shows polymersomes' potential in cancer immunotherapy

byEindhoven University of TechnologySchematic overview of the study. Credit:Nature Nanotechnology(2024). DOI: 10.1038/s41565-024-01727-wWithin an international collaboration of 30 sc

Updated on:August 28,2024